| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 25576 |
| 1 | GUSELKUMAB | 12395 |
| 2 | USTEKINUMAB | 10242 |
| 3 | LENALIDOMIDE | 10080 |
| 4 | ALBUTEROL SULFATE | 9593 |
| 5 | ERGOCALCIFEROL | 9232 |
| 6 | ACETAMINOPHEN | 7285 |
| 7 | PREDNISONE | 7063 |
| 8 | MEPOLIZUMAB | 6869 |
| 9 | ASPIRIN | 6561 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLIMUMAB | 5329 | 0.4232 |
| 1 | NEMOLIZUMAB-ILTO | 5792 | 0.3636 |
| 2 | INFLIXIMAB-DYYB | 1227 | 0.3561 |
| 3 | GUSELKUMAB | 12395 | 0.3243 |
| 4 | ERGOCALCIFEROL | 9232 | 0.3105 |
| 5 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 1096 | 0.3044 |
| 6 | ETEPLIRSEN | 697 | 0.2887 |
| 7 | VOXELOTOR | 5172 | 0.2318 |
| 8 | CENOBAMATE | 1880 | 0.2204 |
| 9 | BIMEKIZUMAB | 4798 | 0.1823 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 25576 |
| 1 | Interleukin-23 Antagonist [EPC] | 23272 |
| 2 | Corticosteroid [EPC] | 16726 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15779 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 15423 |
| 5 | Thalidomide Analog [EPC] | 12356 |
| 6 | Interleukin-12 Antagonist [EPC] | 10264 |
| 7 | GLP-1 Receptor Agonist [EPC] | 9719 |
| 8 | Provitamin D2 Compound [EPC] | 9232 |
| 9 | Kinase Inhibitor [EPC] | 9067 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6882 | 10.0029 |
| 1 | Adrenocorticotropic Hormone [EPC] | 339 | 0.3788 |
| 2 | Interleukin-31 Receptor alpha Antagonist [EPC] | 5792 | 0.3636 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 648 | 0.3123 |
| 4 | Provitamin D2 Compound [EPC] | 9232 | 0.3103 |
| 5 | Farnesyltransferase Inhibitor [EPC] | 23 | 0.2949 |
| 6 | Hemoglobin S Polymerization Inhibitor [EPC] | 5172 | 0.2318 |
| 7 | Interleukin-23 Antagonist [EPC] | 23272 | 0.2222 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 5154 | 0.1609 |
| 9 | Interleukin-17A Antagonist [EPC] | 5803 | 0.1556 |